Wird geladen...

042. Denosumab-associated osteonecrosis of the jaw in NSCLC patient: a case report

BACKGROUND: Osteonecrosis of the jaw (ONJ) following bisphosphonate use is well documented. However, to our knowledge, there are few cases reported on ONJ related to the use of other pharmaceutical agents, such as denosumab—a receptor activator of nuclear factor kappa-B ligand (RANKL) inhibitor that...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Thorac Dis
Hauptverfasser: Boutsikou, Efimia, Dalampiras, Stergios, Zarogoulidis, Paul, Spyratos, Dionysios, Porpodis, Konstantinos, Eleptheriadou, Ellada, Zarogoulidis, Konstantinos
Format: Artigo
Sprache:Inglês
Veröffentlicht: AME Publishing Company 2015
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4332111/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2015.AB042
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!